Viveve Medical Stock Working Capital
| VIVEDelisted Stock | USD 0.1 0.0005 0.53% |
Viveve Medical fundamentals help investors to digest information that contributes to Viveve Medical's financial success or failures. It also enables traders to predict the movement of Viveve Pink Sheet. The fundamental analysis module provides a way to measure Viveve Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Viveve Medical pink sheet.
Viveve |
Viveve Medical Company Working Capital Analysis
Viveve Medical's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Viveve Medical Working Capital | 13.21 M |
Most of Viveve Medical's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Viveve Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAs per the company's disclosures, Viveve Medical has a Working Capital of 13.21 M. This is 96.9% lower than that of the Health Care Equipment & Supplies sector and 99.03% lower than that of the Health Care industry. The working capital for all United States stocks is 99.11% higher than that of the company.
Viveve Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Viveve Medical's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Viveve Medical could also be used in its relative valuation, which is a method of valuing Viveve Medical by comparing valuation metrics of similar companies.Viveve Medical is currently under evaluation in working capital category among its peers.
Viveve Fundamentals
| Return On Equity | -2.11 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (3.10) % | ||||
| Current Valuation | 4.26 M | ||||
| Shares Outstanding | 10.72 M | ||||
| Shares Owned By Institutions | 5.21 % | ||||
| Number Of Shares Shorted | 374.24 K | ||||
| Price To Earning | (2.59) X | ||||
| Price To Book | 3.62 X | ||||
| Price To Sales | 0.66 X | ||||
| Revenue | 6.43 M | ||||
| Gross Profit | 620 K | ||||
| EBITDA | (19.89 M) | ||||
| Net Income | (22.03 M) | ||||
| Cash And Equivalents | 9.43 M | ||||
| Cash Per Share | 0.88 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 1.12 % | ||||
| Current Ratio | 1.32 X | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (12.88 M) | ||||
| Short Ratio | 4.15 X | ||||
| Earnings Per Share | (2.55) X | ||||
| Price To Earnings To Growth | (0.13) X | ||||
| Target Price | 3.1 | ||||
| Number Of Employees | 47 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 1.08 M | ||||
| Total Asset | 25.91 M | ||||
| Retained Earnings | (68.62 M) | ||||
| Working Capital | 13.21 M | ||||
| Current Asset | 18.53 M | ||||
| Current Liabilities | 5.32 M | ||||
| Z Score | -2.8 | ||||
| Net Asset | 25.91 M |
About Viveve Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viveve Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viveve Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viveve Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Viveve Pink Sheet
If you are still planning to invest in Viveve Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viveve Medical's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |